 | • レポートコード：QY2108PAL8772 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、168ページ • 納品方法：Eメール（納期：1日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の当調査資料ではグローバルにおける抗生物質APIの市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、抗生物質APIの種類別市場規模（ペニシリン、セファロスポリン、アミノグリコシド、テトラサイクリン、キノロン、マクロライド、リンコマイシン、その他）、用途別市場規模（経口薬、注射薬）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界の抗生物質API市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界における抗生物質APIの種類別市場規模（2016年-2027年）：ペニシリン、セファロスポリン、アミノグリコシド、テトラサイクリン、キノロン、マクロライド、リンコマイシン、その他 ・世界における抗生物質APIの用途別市場規模（2016年-2027年）：経口薬、注射薬 ・抗生物質APIの中国市場分析 - 抗生物質APIの中国市場規模（2016年-2027年） - 中国における抗生物質APIの主要プレイヤー別市場シェア - 中国における抗生物質APIの種類別市場規模：ペニシリン、セファロスポリン、アミノグリコシド、テトラサイクリン、キノロン、マクロライド、リンコマイシン、その他 - 中国における抗生物質APIの用途別市場規模：経口薬、注射薬 ・抗生物質APIの北米市場（2016年-2027年） ・抗生物質APIのヨーロッパ市場（2016年-2027年） ・抗生物質APIのアジア太平洋市場（2016年-2027年） ・抗生物質APIの中南米市場（2016年-2027年） ・抗生物質APIの中東・アフリカ市場（2016年-2027年） ・主要プレイヤーの情報：UNITED LABORATORIES、North China Pharmaceutical、RUIYING PIONEER PHARMACEUTICAL、Centrient Pharmaceuticals、Aurobindo Pharma、Shyndec Pharmaceutical、Nectar Lifesciences、Harbin Pharmaceutical Group、ACS Dobfar、Novartis、CSPC、QILU ANTIBIOTICS PHARMACEUTICAL、REYOUNG、Orchid Pharma、FUAN PHARMACEUTICAL、Dongying Pharmaceutical、FUKANG PHARMACEUTICAL、Medya Pharmaceutical、LUKANG PHARMACEUTICAL、Dawnrays Pharmaceutical、SALUBRIS、KELUN、HUAFANG PHARMACEUTICAL ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・... |
Antibiotics refer to a class of secondary metabolites with anti-pathogen or other activities produced by bacteria, fungi and other microorganisms or higher animals and plants during their lives. They are chemical substances that can interfere with the development of other living cells. Commonly used clinical antibiotics include extracts from microbial cultures and chemically synthesized or semi-synthetic compounds. This report only counts antibiotic raw materials, excluding various intermediates and penicillin industrial salts.
China is the world’s largest producer and consumer of Antibiotic API, with sales accounting for more than 15% of the global market share. At present, major global manufacturers include UNITED LABORATORIES, North China Pharmaceutical, Centrient Pharmaceuticals, Shyndec Pharmaceutical, RUIYING PIONEER PHARMACEUTICAL, Aurobindo Pharma, etc. The top five manufacturers account for more than 25%. Antibiotic API mainly include penicillins, cephalosporins, aminoglycosides, tetracyclines, etc., which are administered orally or by injection.
Market Analysis and Insights: Global and China Antibiotic API Market
This report focuses on global and China Antibiotic API market.
In 2020, the global Antibiotic API market size was US$ 5626.1 million and it is expected to reach US$ 5290.7 million by the end of 2027, with a CAGR of -0.9% during 2021-2027. In China the Antibiotic API market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Antibiotic API Scope and Market Size
Antibiotic API market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Antibiotic API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Antibiotic API market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
Penicillins
Cephalosporins
Aminoglycosides
Tetracyclines
Quinolones
Macrolides
Lincomycins
Others
Segment by Application
Oral Medicine
Injection Medicine
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
UNITED LABORATORIES
North China Pharmaceutical
RUIYING PIONEER PHARMACEUTICAL
Centrient Pharmaceuticals
Aurobindo Pharma
Shyndec Pharmaceutical
Nectar Lifesciences
Harbin Pharmaceutical Group
ACS Dobfar
Novartis
CSPC
QILU ANTIBIOTICS PHARMACEUTICAL
REYOUNG
Orchid Pharma
FUAN PHARMACEUTICAL
Dongying Pharmaceutical
FUKANG PHARMACEUTICAL
Medya Pharmaceutical
LUKANG PHARMACEUTICAL
Dawnrays Pharmaceutical
SALUBRIS
KELUN
HUAFANG PHARMACEUTICAL
1 Study Coverage
1.1 Antibiotic API Product Introduction
1.2 Market by Type
1.2.1 Global Antibiotic API Market Size Growth Rate by Type
1.2.2 Penicillins
1.2.3 Cephalosporins
1.2.4 Aminoglycosides
1.2.5 Tetracyclines
1.2.6 Quinolones
1.2.7 Macrolides
1.2.8 Lincomycins
1.2.9 Others
1.3 Market by Application
1.3.1 Global Antibiotic API Market Size Growth Rate by Application
1.3.2 Oral Medicine
1.3.3 Injection Medicine
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Antibiotic API Market Size, Estimates and Forecasts
2.1.1 Global Antibiotic API Revenue 2016-2027
2.1.2 Global Antibiotic API Sales 2016-2027
2.2 Global Antibiotic API, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Antibiotic API Historical Market Size by Region (2016-2021)
2.3.1 Global Antibiotic API Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Antibiotic API Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Antibiotic API Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Antibiotic API Sales Forecast by Region (2022-2027)
2.4.2 Global Antibiotic API Revenue Forecast by Region (2022-2027)
3 Global Antibiotic API Competitor Landscape by Players
3.1 Global Top Antibiotic API Manufacturers by Sales
3.1.1 Global Antibiotic API Sales by Manufacturer (2016-2021)
3.1.2 Global Antibiotic API Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Antibiotic API Manufacturers by Revenue
3.2.1 Key Antibiotic API Manufacturers Covered: Ranking by Revenue
3.2.2 Global Antibiotic API Revenue by Manufacturers (2016-2021)
3.2.3 Global Antibiotic API Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Antibiotic API Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Antibiotic API Revenue in 2020
3.2.6 Global Antibiotic API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Antibiotic API Price by Manufacturers
3.4 Global Antibiotic API Manufacturing Base Distribution, Product Types
3.4.1 Antibiotic API Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antibiotic API Product Type
3.4.3 Date of International Manufacturers Enter into Antibiotic API Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Antibiotic API Market Size by Type (2016-2021)
4.1.1 Global Antibiotic API Sales by Type (2016-2021)
4.1.2 Global Antibiotic API Revenue by Type (2016-2021)
4.1.3 Antibiotic API Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Antibiotic API Market Size Forecast by Type (2022-2027)
4.2.1 Global Antibiotic API Sales Forecast by Type (2022-2027)
4.2.2 Global Antibiotic API Revenue Forecast by Type (2022-2027)
4.2.3 Antibiotic API Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Antibiotic API Market Size by Application (2016-2021)
5.1.1 Global Antibiotic API Sales by Application (2016-2021)
5.1.2 Global Antibiotic API Revenue by Application (2016-2021)
5.1.3 Antibiotic API Price by Application (2016-2021)
5.2 Antibiotic API Market Size Forecast by Application (2022-2027)
5.2.1 Global Antibiotic API Sales Forecast by Application (2022-2027)
5.2.2 Global Antibiotic API Revenue Forecast by Application (2022-2027)
5.2.3 Global Antibiotic API Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Antibiotic API Market Size YoY Growth 2016-2027
6.1.1 China Antibiotic API Sales YoY Growth 2016-2027
6.1.2 China Antibiotic API Revenue YoY Growth 2016-2027
6.1.3 China Antibiotic API Market Share in Global Market 2016-2027
6.2 China Antibiotic API Market Size by Players (International and Local Players)
6.2.1 China Top Antibiotic API Players by Sales (2016-2021)
6.2.2 China Top Antibiotic API Players by Revenue (2016-2021)
6.3 China Antibiotic API Historic Market Review by Type (2016-2021)
6.3.1 China Antibiotic API Sales Market Share by Type (2016-2021)
6.3.2 China Antibiotic API Revenue Market Share by Type (2016-2021)
6.3.3 China Antibiotic API Price by Type (2016-2021)
6.4 China Antibiotic API Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Antibiotic API Sales Forecast by Type (2022-2027)
6.4.2 China Antibiotic API Revenue Forecast by Type (2022-2027)
6.4.3 China Antibiotic API Price Forecast by Type (2022-2027)
6.5 China Antibiotic API Historic Market Review by Application (2016-2021)
6.5.1 China Antibiotic API Sales Market Share by Application (2016-2021)
6.5.2 China Antibiotic API Revenue Market Share by Application (2016-2021)
6.5.3 China Antibiotic API Price by Application (2016-2021)
6.6 China Antibiotic API Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Antibiotic API Sales Forecast by Application (2022-2027)
6.6.2 China Antibiotic API Revenue Forecast by Application (2022-2027)
6.6.3 China Antibiotic API Price Forecast by Application (2022-2027)
7 North America
7.1 North America Antibiotic API Market Size YoY Growth 2016-2027
7.2 North America Antibiotic API Market Facts & Figures by Country
7.2.1 North America Antibiotic API Sales by Country (2016-2021)
7.2.2 North America Antibiotic API Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Antibiotic API Market Size YoY Growth 2016-2027
8.2 Asia Pacific Antibiotic API Market Facts & Figures by Region
8.2.1 Asia Pacific Antibiotic API Sales by Region (2016-2021)
8.2.2 Asia Pacific Antibiotic API Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Antibiotic API Market Size YoY Growth 2016-2027
9.2 Europe Antibiotic API Market Facts & Figures by Country
9.2.1 Europe Antibiotic API Sales by Country (2016-2021)
9.2.2 Europe Antibiotic API Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Antibiotic API Market Size YoY Growth 2016-2027
10.2 Latin America Antibiotic API Market Facts & Figures by Country
10.2.1 Latin America Antibiotic API Sales by Country (2016-2021)
10.2.2 Latin America Antibiotic API Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Antibiotic API Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Antibiotic API Market Facts & Figures by Country
11.2.1 Middle East and Africa Antibiotic API Sales by Country (2016-2021)
11.2.2 Middle East and Africa Antibiotic API Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 UNITED LABORATORIES
12.1.1 UNITED LABORATORIES Corporation Information
12.1.2 UNITED LABORATORIES Description and Business Overview
12.1.3 UNITED LABORATORIES Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
12.1.4 UNITED LABORATORIES Antibiotic API Products Offered
12.1.5 UNITED LABORATORIES Recent Development
12.2 North China Pharmaceutical
12.2.1 North China Pharmaceutical Corporation Information
12.2.2 North China Pharmaceutical Description and Business Overview
12.2.3 North China Pharmaceutical Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
12.2.4 North China Pharmaceutical Antibiotic API Products Offered
12.2.5 North China Pharmaceutical Recent Development
12.3 RUIYING PIONEER PHARMACEUTICAL
12.3.1 RUIYING PIONEER PHARMACEUTICAL Corporation Information
12.3.2 RUIYING PIONEER PHARMACEUTICAL Description and Business Overview
12.3.3 RUIYING PIONEER PHARMACEUTICAL Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
12.3.4 RUIYING PIONEER PHARMACEUTICAL Antibiotic API Products Offered
12.3.5 RUIYING PIONEER PHARMACEUTICAL Recent Development
12.4 Centrient Pharmaceuticals
12.4.1 Centrient Pharmaceuticals Corporation Information
12.4.2 Centrient Pharmaceuticals Description and Business Overview
12.4.3 Centrient Pharmaceuticals Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Centrient Pharmaceuticals Antibiotic API Products Offered
12.4.5 Centrient Pharmaceuticals Recent Development
12.5 Aurobindo Pharma
12.5.1 Aurobindo Pharma Corporation Information
12.5.2 Aurobindo Pharma Description and Business Overview
12.5.3 Aurobindo Pharma Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Aurobindo Pharma Antibiotic API Products Offered
12.5.5 Aurobindo Pharma Recent Development
12.6 Shyndec Pharmaceutical
12.6.1 Shyndec Pharmaceutical Corporation Information
12.6.2 Shyndec Pharmaceutical Description and Business Overview
12.6.3 Shyndec Pharmaceutical Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Shyndec Pharmaceutical Antibiotic API Products Offered
12.6.5 Shyndec Pharmaceutical Recent Development
12.7 Nectar Lifesciences
12.7.1 Nectar Lifesciences Corporation Information
12.7.2 Nectar Lifesciences Description and Business Overview
12.7.3 Nectar Lifesciences Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Nectar Lifesciences Antibiotic API Products Offered
12.7.5 Nectar Lifesciences Recent Development
12.8 Harbin Pharmaceutical Group
12.8.1 Harbin Pharmaceutical Group Corporation Information
12.8.2 Harbin Pharmaceutical Group Description and Business Overview
12.8.3 Harbin Pharmaceutical Group Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Harbin Pharmaceutical Group Antibiotic API Products Offered
12.8.5 Harbin Pharmaceutical Group Recent Development
12.9 ACS Dobfar
12.9.1 ACS Dobfar Corporation Information
12.9.2 ACS Dobfar Description and Business Overview
12.9.3 ACS Dobfar Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
12.9.4 ACS Dobfar Antibiotic API Products Offered
12.9.5 ACS Dobfar Recent Development
12.10 Novartis
12.10.1 Novartis Corporation Information
12.10.2 Novartis Description and Business Overview
12.10.3 Novartis Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Novartis Antibiotic API Products Offered
12.10.5 Novartis Recent Development
12.11 UNITED LABORATORIES
12.11.1 UNITED LABORATORIES Corporation Information
12.11.2 UNITED LABORATORIES Description and Business Overview
12.11.3 UNITED LABORATORIES Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
12.11.4 UNITED LABORATORIES Antibiotic API Products Offered
12.11.5 UNITED LABORATORIES Recent Development
12.12 QILU ANTIBIOTICS PHARMACEUTICAL
12.12.1 QILU ANTIBIOTICS PHARMACEUTICAL Corporation Information
12.12.2 QILU ANTIBIOTICS PHARMACEUTICAL Description and Business Overview
12.12.3 QILU ANTIBIOTICS PHARMACEUTICAL Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
12.12.4 QILU ANTIBIOTICS PHARMACEUTICAL Products Offered
12.12.5 QILU ANTIBIOTICS PHARMACEUTICAL Recent Development
12.13 REYOUNG
12.13.1 REYOUNG Corporation Information
12.13.2 REYOUNG Description and Business Overview
12.13.3 REYOUNG Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
12.13.4 REYOUNG Products Offered
12.13.5 REYOUNG Recent Development
12.14 Orchid Pharma
12.14.1 Orchid Pharma Corporation Information
12.14.2 Orchid Pharma Description and Business Overview
12.14.3 Orchid Pharma Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Orchid Pharma Products Offered
12.14.5 Orchid Pharma Recent Development
12.15 FUAN PHARMACEUTICAL
12.15.1 FUAN PHARMACEUTICAL Corporation Information
12.15.2 FUAN PHARMACEUTICAL Description and Business Overview
12.15.3 FUAN PHARMACEUTICAL Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
12.15.4 FUAN PHARMACEUTICAL Products Offered
12.15.5 FUAN PHARMACEUTICAL Recent Development
12.16 Dongying Pharmaceutical
12.16.1 Dongying Pharmaceutical Corporation Information
12.16.2 Dongying Pharmaceutical Description and Business Overview
12.16.3 Dongying Pharmaceutical Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Dongying Pharmaceutical Products Offered
12.16.5 Dongying Pharmaceutical Recent Development
12.17 FUKANG PHARMACEUTICAL
12.17.1 FUKANG PHARMACEUTICAL Corporation Information
12.17.2 FUKANG PHARMACEUTICAL Description and Business Overview
12.17.3 FUKANG PHARMACEUTICAL Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
12.17.4 FUKANG PHARMACEUTICAL Products Offered
12.17.5 FUKANG PHARMACEUTICAL Recent Development
12.18 Medya Pharmaceutical
12.18.1 Medya Pharmaceutical Corporation Information
12.18.2 Medya Pharmaceutical Description and Business Overview
12.18.3 Medya Pharmaceutical Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Medya Pharmaceutical Products Offered
12.18.5 Medya Pharmaceutical Recent Development
12.19 LUKANG PHARMACEUTICAL
12.19.1 LUKANG PHARMACEUTICAL Corporation Information
12.19.2 LUKANG PHARMACEUTICAL Description and Business Overview
12.19.3 LUKANG PHARMACEUTICAL Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
12.19.4 LUKANG PHARMACEUTICAL Products Offered
12.19.5 LUKANG PHARMACEUTICAL Recent Development
12.20 Dawnrays Pharmaceutical
12.20.1 Dawnrays Pharmaceutical Corporation Information
12.20.2 Dawnrays Pharmaceutical Description and Business Overview
12.20.3 Dawnrays Pharmaceutical Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Dawnrays Pharmaceutical Products Offered
12.20.5 Dawnrays Pharmaceutical Recent Development
12.21 SALUBRIS
12.21.1 SALUBRIS Corporation Information
12.21.2 SALUBRIS Description and Business Overview
12.21.3 SALUBRIS Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
12.21.4 SALUBRIS Products Offered
12.21.5 SALUBRIS Recent Development
12.22 KELUN
12.22.1 KELUN Corporation Information
12.22.2 KELUN Description and Business Overview
12.22.3 KELUN Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
12.22.4 KELUN Products Offered
12.22.5 KELUN Recent Development
12.23 HUAFANG PHARMACEUTICAL
12.23.1 HUAFANG PHARMACEUTICAL Corporation Information
12.23.2 HUAFANG PHARMACEUTICAL Description and Business Overview
12.23.3 HUAFANG PHARMACEUTICAL Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
12.23.4 HUAFANG PHARMACEUTICAL Products Offered
12.23.5 HUAFANG PHARMACEUTICAL Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Antibiotic API Industry Trends
13.2 Antibiotic API Market Drivers
13.3 Antibiotic API Market Challenges
13.4 Antibiotic API Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antibiotic API Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Antibiotic API Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Penicillins
Table 3. Major Manufacturers of Cephalosporins
Table 4. Major Manufacturers of Aminoglycosides
Table 5. Major Manufacturers of Tetracyclines
Table 6. Major Manufacturers of Quinolones
Table 7. Major Manufacturers of Macrolides
Table 8. Major Manufacturers of Lincomycins
Table 9. Major Manufacturers of Others
Table 10. Global Antibiotic API Market Size Growth Rate by Application (2021-2027) & (Tons)
Table 11. Global Antibiotic API Market Size by Region (Tons) & (US$ Million), 2016 VS 2021 VS 2027
Table 12. Global Antibiotic API Sales by Regions (2016-2021) & (Tons)
Table 13. Global Antibiotic API Sales Market Share by Regions (2016-2021)
Table 14. Global Antibiotic API Revenue by Regions (2016-2021) & (US$ Million)
Table 15. Global Antibiotic API Sales Forecast by Region (2022-2027) & (Tons)
Table 16. Global Antibiotic API Sales Market Share Forecast by Region (2022-2027)
Table 17. Global Antibiotic API Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 18. Global Antibiotic API Revenue Market Share Forecast by Region (2022-2027)
Table 19. Global Antibiotic API Sales by Manufacturers (2016-2021) (Tons)
Table 20. Global Antibiotic API Sales Share by Manufacturers (2016-2021)
Table 21. Ranking of Global Top Antibiotic API Manufacturers by Revenue (US$ Million) in 2020
Table 22. Antibiotic API Revenue by Manufacturers (2016-2021) (US$ Million)
Table 23. Antibiotic API Revenue Share by Manufacturers (2016-2021)
Table 24. Global Antibiotic API Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 25. Global Antibiotic API by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibiotic API as of 2020)
Table 26. Key Manufacturers Antibiotic API Price (2016-2021) (USD/Kg)
Table 27. Antibiotic API Manufacturers Manufacturing Base Distribution and Headquarters
Table 28. Manufacturers Antibiotic API Product Type
Table 29. Date of International Manufacturers Enter into Antibiotic API Market
Table 30. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 31. Global Antibiotic API Sales by Type (2016-2021) (Tons)
Table 32. Global Antibiotic API Sales Share by Type (2016-2021)
Table 33. Global Antibiotic API Revenue by Type (2016-2021) (US$ Million)
Table 34. Global Antibiotic API Revenue Share by Type (2016-2021)
Table 35. Antibiotic API Average Selling Price (ASP) by Type (2016-2021) & (USD/Kg)
Table 36. Global Antibiotic API Sales Forecast by Type (2022-2027) & (Tons)
Table 37. Global Antibiotic API Sales Market Share Forecast by Type (2022-2027)
Table 38. Global Antibiotic API Revenue Forecast V (2022-2027) & (US$ Million)
Table 39. Global Antibiotic API Revenue Market Share Forecast by Type (2022-2027)
Table 40. Global Antibiotic API Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Kg)
Table 41. Global Antibiotic API Sales by Application (2016-2021) (Tons)
Table 42. Global Antibiotic API Sales Share by Application (2016-2021)
Table 43. Global Antibiotic API Revenue by Application (2016-2021) (US$ Million)
Table 44. Global Antibiotic API Revenue Share by Application (2016-2021)
Table 45. Antibiotic API Average Selling Price (ASP) by Application (2016-2021) & (USD/Kg)
Table 46. Global Antibiotic API Sales Forecast by Application (2022-2027) & (Tons)
Table 47. Global Antibiotic API Sales Market Share Forecast by Application (2022-2027)
Table 48. Global Antibiotic API Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 49. Global Antibiotic API Revenue Market Share Forecast by Application (2022-2027)
Table 50. Global Antibiotic API Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Kg)
Table 51. China Antibiotic API Sales (Tons) of Key Companies (2016-2021)
Table 52. China Antibiotic API Sales Share by Company (2016-2021)
Table 53. China Antibiotic API Revenue (US$ Million) by Company (2016-2021)
Table 54. China Antibiotic API Revenue Share by Company (2016-2021)
Table 55. China Antibiotic API Sales (Tons) by Type (2016-2021)
Table 56. China Antibiotic API Sales Share by Type (2016-2021)
Table 57. China Antibiotic API Revenue (US$ Million) Market Share by Type (2016-2021)
Table 58. China Antibiotic API Price (USD/Kg) by Type (2016-2021)
Table 59. China Antibiotic API Sales (Tons) by Type (2022-2027)
Table 60. China Antibiotic API Sales Share by Type (2022-2027)
Table 61. China Antibiotic API Revenue (US$ Million) Market Share by Type (2022-2027)
Table 62. China Antibiotic API Revenue Share by Type (2022-2027)
Table 63. China Antibiotic API Price (USD/Kg) by Type (2022-2027)
Table 64. China Antibiotic API Sales (Tons) by Application (2016-2021)
Table 65. China Antibiotic API Sales Share by Application (2016-2021)
Table 66. China Antibiotic API Revenue (US$ Million) Market Share by Application (2016-2021)
Table 67. China Antibiotic API Price (USD/Kg) by Application (2016-2021)
Table 68. China Antibiotic API Sales (Tons) by Application (2022-2027)
Table 69. China Antibiotic API Sales Share by Application (2022-2027)
Table 70. China Antibiotic API Revenue (US$ Million) Market Share by Application (2022-2027)
Table 71. China Antibiotic API Revenue Share by Application (2022-2027)
Table 72. China Antibiotic API Price (USD/Kg) by Application (2022-2027)
Table 73. North America Antibiotic API Sales by Country (2016-2021) & (Tons)
Table 74. North America Antibiotic API Sales Market Share by Country (2016-2021)
Table 75. North America Antibiotic API Revenue by Country (2016-2021) & (US$ Million)
Table 76. North America Antibiotic API Revenue Market Share by Country (2016-2021)
Table 77. Asia Pacific Antibiotic API Sales by Region (2016-2021) & (Tons)
Table 78. Asia Pacific Antibiotic API Sales Market Share by Region (2016-2021)
Table 79. Asia Pacific Antibiotic API Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Antibiotic API Revenue Market Share by Region (2016-2021)
Table 81. Europe Antibiotic API Sales by Country (2016-2021) & (Tons)
Table 82. Europe Antibiotic API Sales Market Share by Country (2016-2021)
Table 83. Europe Antibiotic API Revenue by Country (2016-2021) & (US$ Million)
Table 84. Europe Antibiotic API Revenue Market Share by Country (2016-2021)
Table 85. Latin America Antibiotic API Sales by Country (2016-2021) & (Tons)
Table 86. Latin America Antibiotic API Sales Market Share by Country (2016-2021)
Table 87. Latin Americaa Antibiotic API Revenue by Country (2016-2021) & (US$ Million)
Table 88. Latin America Antibiotic API Revenue Market Share by Country (2016-2021)
Table 89. Middle East and Africa Antibiotic API Sales by Country (2016-2021) & (Tons)
Table 90. Middle East and Africa Antibiotic API Sales Market Share by Country (2016-2021)
Table 91. Middle East and Africa Antibiotic API Revenue by Country (2016-2021) & (US$ Million)
Table 92. Middle East and Africa Antibiotic API Revenue Market Share by Country (2016-2021)
Table 93. UNITED LABORATORIES Corporation Information
Table 94. UNITED LABORATORIES Description and Business Overview
Table 95. UNITED LABORATORIES Antibiotic API Sales (Tons), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 96. UNITED LABORATORIES Antibiotic API Product
Table 97. UNITED LABORATORIES Recent Development
Table 98. North China Pharmaceutical Corporation Information
Table 99. North China Pharmaceutical Description and Business Overview
Table 100. North China Pharmaceutical Antibiotic API Sales (Tons), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 101. North China Pharmaceutical Product
Table 102. North China Pharmaceutical Recent Development
Table 103. RUIYING PIONEER PHARMACEUTICAL Corporation Information
Table 104. RUIYING PIONEER PHARMACEUTICAL Description and Business Overview
Table 105. RUIYING PIONEER PHARMACEUTICAL Antibiotic API Sales (Tons), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 106. RUIYING PIONEER PHARMACEUTICAL Product
Table 107. RUIYING PIONEER PHARMACEUTICAL Recent Development
Table 108. Centrient Pharmaceuticals Corporation Information
Table 109. Centrient Pharmaceuticals Description and Business Overview
Table 110. Centrient Pharmaceuticals Antibiotic API Sales (Tons), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 111. Centrient Pharmaceuticals Product
Table 112. Centrient Pharmaceuticals Recent Development
Table 113. Aurobindo Pharma Corporation Information
Table 114. Aurobindo Pharma Description and Business Overview
Table 115. Aurobindo Pharma Antibiotic API Sales (Tons), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 116. Aurobindo Pharma Product
Table 117. Aurobindo Pharma Recent Development
Table 118. Shyndec Pharmaceutical Corporation Information
Table 119. Shyndec Pharmaceutical Description and Business Overview
Table 120. Shyndec Pharmaceutical Antibiotic API Sales (Tons), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 121. Shyndec Pharmaceutical Product
Table 122. Shyndec Pharmaceutical Recent Development
Table 123. Nectar Lifesciences Corporation Information
Table 124. Nectar Lifesciences Description and Business Overview
Table 125. Nectar Lifesciences Antibiotic API Sales (Tons), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 126. Nectar Lifesciences Product
Table 127. Nectar Lifesciences Recent Development
Table 128. Harbin Pharmaceutical Group Corporation Information
Table 129. Harbin Pharmaceutical Group Description and Business Overview
Table 130. Harbin Pharmaceutical Group Antibiotic API Sales (Tons), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 131. Harbin Pharmaceutical Group Product
Table 132. Harbin Pharmaceutical Group Recent Development
Table 133. ACS Dobfar Corporation Information
Table 134. ACS Dobfar Description and Business Overview
Table 135. ACS Dobfar Antibiotic API Sales (Tons), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 136. ACS Dobfar Product
Table 137. ACS Dobfar Recent Development
Table 138. Novartis Corporation Information
Table 139. Novartis Description and Business Overview
Table 140. Novartis Antibiotic API Sales (Tons), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 141. Novartis Product
Table 142. Novartis Recent Development
Table 143. CSPC Corporation Information
Table 144. CSPC Description and Business Overview
Table 145. CSPC Antibiotic API Sales (Tons), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 146. CSPC Product
Table 147. CSPC Recent Development
Table 148. QILU ANTIBIOTICS PHARMACEUTICAL Corporation Information
Table 149. QILU ANTIBIOTICS PHARMACEUTICAL Description and Business Overview
Table 150. QILU ANTIBIOTICS PHARMACEUTICAL Antibiotic API Sales (Tons), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 151. QILU ANTIBIOTICS PHARMACEUTICAL Product
Table 152. QILU ANTIBIOTICS PHARMACEUTICAL Recent Development
Table 153. REYOUNG Corporation Information
Table 154. REYOUNG Description and Business Overview
Table 155. REYOUNG Antibiotic API Sales (Tons), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 156. REYOUNG Product
Table 157. REYOUNG Recent Development
Table 158. Orchid Pharma Corporation Information
Table 159. Orchid Pharma Description and Business Overview
Table 160. Orchid Pharma Antibiotic API Sales (Tons), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 161. Orchid Pharma Product
Table 162. Orchid Pharma Recent Development
Table 163. FUAN PHARMACEUTICAL Corporation Information
Table 164. FUAN PHARMACEUTICAL Description and Business Overview
Table 165. FUAN PHARMACEUTICAL Antibiotic API Sales (Tons), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 166. FUAN PHARMACEUTICAL Product
Table 167. FUAN PHARMACEUTICAL Recent Development
Table 168. Dongying Pharmaceutical Corporation Information
Table 169. Dongying Pharmaceutical Description and Business Overview
Table 170. Dongying Pharmaceutical Antibiotic API Sales (Tons), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 171. Dongying Pharmaceutical Product
Table 172. Dongying Pharmaceutical Recent Development
Table 173. FUKANG PHARMACEUTICAL Corporation Information
Table 174. FUKANG PHARMACEUTICAL Description and Business Overview
Table 175. FUKANG PHARMACEUTICAL Antibiotic API Sales (Tons), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 176. FUKANG PHARMACEUTICAL Product
Table 177. FUKANG PHARMACEUTICAL Recent Development
Table 178. Medya Pharmaceutical Corporation Information
Table 179. Medya Pharmaceutical Description and Business Overview
Table 180. Medya Pharmaceutical Antibiotic API Sales (Tons), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 181. Medya Pharmaceutical Product
Table 182. Medya Pharmaceutical Recent Development
Table 183. LUKANG PHARMACEUTICAL Corporation Information
Table 184. LUKANG PHARMACEUTICAL Description and Business Overview
Table 185. LUKANG PHARMACEUTICAL Antibiotic API Sales (Tons), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 186. LUKANG PHARMACEUTICAL Product
Table 187. LUKANG PHARMACEUTICAL Recent Development
Table 188. Dawnrays Pharmaceutical Corporation Information
Table 189. Dawnrays Pharmaceutical Description and Business Overview
Table 190. Dawnrays Pharmaceutical Antibiotic API Sales (Tons), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 191. Dawnrays Pharmaceutical Product
Table 192. Dawnrays Pharmaceutical Recent Development
Table 193. SALUBRIS Corporation Information
Table 194. SALUBRIS Description and Business Overview
Table 195. SALUBRIS Antibiotic API Sales (Tons), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 196. SALUBRIS Product
Table 197. SALUBRIS Recent Development
Table 198. KELUN Corporation Information
Table 199. KELUN Description and Business Overview
Table 200. KELUN Antibiotic API Sales (Tons), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 201. KELUN Product
Table 202. KELUN Recent Development
Table 203. HUAFANG PHARMACEUTICAL Corporation Information
Table 204. HUAFANG PHARMACEUTICAL Description and Business Overview
Table 205. HUAFANG PHARMACEUTICAL Antibiotic API Sales (Tons), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 206. HUAFANG PHARMACEUTICAL Product
Table 207. HUAFANG PHARMACEUTICAL Recent Development
Table 208. Antibiotic API Market Trends
Table 209. Antibiotic API Market Drivers
Table 210. Antibiotic API Market Challenges
Table 211. Antibiotic API Market Restraints
Table 212. Antibiotic API Customers List
Table 213. Antibiotic API Distributors List
Table 214. Research Programs/Design for This Report
Table 215. Key Data Information from Secondary Sources
Table 216. Key Data Information from Primary Sources
List of Figures
Figure 1. Antibiotic API Product Picture
Figure 2. Global Antibiotic API Sales Market Share by Type in 2020 & 2027
Figure 3. Penicillins Product Picture
Figure 4. Cephalosporins Product Picture
Figure 5. Aminoglycosides Product Picture
Figure 6. Tetracyclines Product Picture
Figure 7. Quinolones Product Picture
Figure 8. Macrolides Product Picture
Figure 9. Lincomycins Product Picture
Figure 10. Others Product Picture
Figure 11. Global Antibiotic API Sales Market Share by Application in 2020 & 2027
Figure 12. Oral Medicine
Figure 13. Injection Medicine
Figure 14. Antibiotic API Report Years Considered
Figure 15. Global Antibiotic API Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Antibiotic API Market Size 2016-2027 (US$ Million)
Figure 17. Global Antibiotic API Sales 2016-2027 (Tons)
Figure 18. Global Antibiotic API Market Size Market Share by Region: 2021 Versus 2027
Figure 19. Global Antibiotic API Sales Market Share by Region (2016-2021)
Figure 20. Global Antibiotic API Sales Market Share by Region in 2020
Figure 21. Global Antibiotic API Revenue Market Share by Region (2016-2021)
Figure 22. Global Antibiotic API Revenue Market Share by Region in 2020
Figure 23. Global Antibiotic API Sales Share by Manufacturer in 2020
Figure 24. The Top 10 and 5 Players Market Share by Antibiotic API Revenue in 2020
Figure 25. Antibiotic API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 26. Global Antibiotic API Sales Market Share by Type (2016-2021)
Figure 27. Global Antibiotic API Sales Market Share by Type in 2020
Figure 28. Global Antibiotic API Revenue Market Share by Type (2016-2021)
Figure 29. Global Antibiotic API Revenue Market Share by Type in 2020
Figure 30. Global Antibiotic API Sales Market Share by Application (2016-2021)
Figure 31. Global Antibiotic API Sales Market Share by Application in 2020
Figure 32. Global Antibiotic API Revenue Market Share by Application (2016-2021)
Figure 33. Global Antibiotic API Revenue Market Share by Application in 2020
Figure 34. China Antibiotic API Sales Growth Rate 2016-2027 (Tons)
Figure 35. China Antibiotic API Revenue Growth Rate 2016-2027 (US$ Million)
Figure 36. China Antibiotic API Market Share in Global Market 2016-2027
Figure 37. China 5 and 10 Largest Antibiotic API Players Market Share by Revenue in Antibiotic API in 2020
Figure 38. China Antibiotic API Revenue Share by Type (2016-2021)
Figure 39. China Antibiotic API Revenue Growth Rate by Type in 2016 & 2020
Figure 40. China Antibiotic API Revenue Share by Application (2016-2021)
Figure 41. China Antibiotic API Revenue Growth Rate by Application in 2016 & 2020
Figure 42. North America Antibiotic API Sales Growth Rate 2016-2021 (Tons)
Figure 43. North America Antibiotic API Revenue Growth Rate 2016-2021 (US$ Million)
Figure 44. North America Antibiotic API Sales Market Share by Country in 2020
Figure 45. North America Antibiotic API Revenue Market Share by Country in 2020
Figure 46. U.S. Antibiotic API Sales Growth Rate (2016-2021) (Tons)
Figure 47. U.S. Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Canada Antibiotic API Sales Growth Rate (2016-2021) (Tons)
Figure 49. Canada Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Europe Antibiotic API Sales Growth Rate 2016-2021 (Tons)
Figure 51. Europe Antibiotic API Revenue Growth Rate 2016-2021 (US$ Million)
Figure 52. Europe Antibiotic API Sales Market Share by Country in 2020
Figure 53. Europe Antibiotic API Revenue Market Share by Country in 2020
Figure 54. Germany Antibiotic API Sales Growth Rate (2016-2021) (Tons)
Figure 55. Germany Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. France Antibiotic API Sales Growth Rate (2016-2021) (Tons)
Figure 57. France Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. U.K. Antibiotic API Sales Growth Rate (2016-2021) (Tons)
Figure 59. U.K. Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Italy Antibiotic API Sales Growth Rate (2016-2021) (Tons)
Figure 61. Italy Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 62. Russia Antibiotic API Sales Growth Rate (2016-2021) (Tons)
Figure 63. Russia Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 64. Asia Pacific Antibiotic API Sales Growth Rate 2016-2021 (Tons)
Figure 65. Asia Pacific Antibiotic API Revenue Growth Rate 2016-2021 (US$ Million)
Figure 66. Asia Pacific Antibiotic API Sales Market Share by Region in 2020
Figure 67. Asia Pacific Antibiotic API Revenue Market Share by Region in 2020
Figure 68. China Antibiotic API Sales Growth Rate (2016-2021) (Tons)
Figure 69. China Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. Japan Antibiotic API Sales Growth Rate (2016-2021) (Tons)
Figure 71. Japan Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. South Korea Antibiotic API Sales Growth Rate (2016-2021) (Tons)
Figure 73. South Korea Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. India Antibiotic API Sales Growth Rate (2016-2021) (Tons)
Figure 75. India Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Australia Antibiotic API Sales Growth Rate (2016-2021) (Tons)
Figure 77. Australia Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Taiwan Antibiotic API Sales Growth Rate (2016-2021) (Tons)
Figure 79. Taiwan Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Indonesia Antibiotic API Sales Growth Rate (2016-2021) (Tons)
Figure 81. Indonesia Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Thailand Antibiotic API Sales Growth Rate (2016-2021) (Tons)
Figure 83. Thailand Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Malaysia Antibiotic API Sales Growth Rate (2016-2021) (Tons)
Figure 85. Malaysia Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 86. Latin America Antibiotic API Sales Growth Rate 2016-2021 (Tons)
Figure 87. Latin America Antibiotic API Revenue Growth Rate 2016-2021 (US$ Million)
Figure 88. Latin America Antibiotic API Sales Market Share by Country in 2020
Figure 89. Latin America Antibiotic API Revenue Market Share by Country in 2020
Figure 90. Mexico Antibiotic API Sales Growth Rate (2016-2021) (Tons)
Figure 91. Mexico Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Brazil Antibiotic API Sales Growth Rate (2016-2021) (Tons)
Figure 93. Brazil Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 94. Argentina Antibiotic API Sales Growth Rate (2016-2021) (Tons)
Figure 95. Argentina Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 96. Middle East and Africa Antibiotic API Sales Growth Rate 2016-2021 (Tons)
Figure 97. Middle East and Africa Antibiotic API Revenue Growth Rate 2016-2021 (US$ Million)
Figure 98. Middle East and Africa Antibiotic API Sales Market Share by Country in 2020
Figure 99. Middle East and Africa Antibiotic API Revenue Market Share by Country in 2020
Figure 100. Turkey Antibiotic API Sales Growth Rate (2016-2021) (Tons)
Figure 101. Turkey Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 102. Saudi Arabia Antibiotic API Sales Growth Rate (2016-2021) (Tons)
Figure 103. Saudi Arabia Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 104. UAE Antibiotic API Sales Growth Rate (2016-2021) (Tons)
Figure 105. UAE Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 106. Antibiotic API Value Chain
Figure 107. Channels of Distribution
Figure 108. Distributors Profiles
Figure 109. Bottom-up and Top-down Approaches for This Report
Figure 110. Data Triangulation
Figure 111. Key Executives Interviewed
VRE・MRSA抗生物質の世界及び中国市場 Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE) are specific, antibiotic-resistant bacteria that spread by contact and can cause serious infections. MRSA can be spread by touching articles that have been contaminated by the skin of an infected or coloniz…- 核医学・放射性医薬品の世界及び中国市場 Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceuti…
- 喉頭蓋炎治療薬の世界市場 2020年 Market Overview The global Epiglottitis Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Epiglottitis Drug market re…
- 世界のフルニキシンメグルミン注射市場インサイト・予測（～2027年） Flunixin Meglumine Injection is used for febrile diseases, muscle pain and soft tissue pain of livestock and small animals Market Analysis and Insights: Global Flunixin Meglumine Injection Market The global Flunixin Meglumine Injection market is valued at US$ XX million in 2020. The market size will…
- 漢方薬の世界及び中国市場 Herbal medicine--also called botanical medicine or phytomedicine refers to using a plant's seeds, berries, roots, leaves, bark, or flowers for medicinal purposes. Herbalism has a long tradition of use outside of conventional medicine. It is becoming more mainstream as improvements in analysis and qu…